Many analysts are providing their Estimated Earnings analysis for BioScrip, Inc. and for the current quarter 3 analysts have projected that the stock could give an Average Earnings estimate of $-0.06/share. These analysts have also projected a Low Estimate of $-0.11/share and a High Estimate of $-0.04/share.
In case of Revenue Estimates, 4 analysts have provided their consensus Average Revenue Estimates for BioScrip, Inc. as 705.59 Million. According to these analysts, the Low Revenue Estimate for BioScrip, Inc. is 700 Million and the High Revenue Estimate is 708.66 Million. The company had Year Ago Sales of 183.57 Million.
Stoneridge, Inc. (SRI) will report its next earnings on Feb 27 BMO. The company reported the earnings of $0.37/Share in the last quarter where the estimated EPS by analysts was $0.37/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.
Many analysts are providing their Estimated Earnings analysis for Stoneridge, Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $0.35/share. These analysts have also projected a Low Estimate of $0.33/share and a High Estimate of $0.4/share.
In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Stoneridge, Inc. as 182.19 Million. According to these analysts, the Low Revenue Estimate for Stoneridge, Inc. is 166.54 Million and the High Revenue Estimate is 205.5 Million. The company had Year Ago Sales of 210.81 Million.
These analysts also forecasted Growth Estimates for the Current Quarter for SRI to be -21.3%. They are projecting Next Quarter growth of 0%. For the next 5 years, Stoneridge, Inc. is expecting Growth of 10.2% per annum, whereas in the past 5 years the growth was -23.62% per annum.
Some buy side analysts are also providing their Analysis on Stoneridge, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
The Relative Volume of the company is 0.55 and Average Volume (3 months) is 170.21 million. The company’s P/E (price to earnings) ratio is 12.35 and Forward P/E ratio of 17.57.
The company shows its Return on Assets (ROA) value of 11.7%. The Return on Equity (ROE) value stands at 24.1%. While it’s Return on Investment (ROI) value is 14.8%.
While looking at the Stock’s Performance, Stoneridge, Inc. currently shows a Weekly Performance of 4.3%, where Monthly Performance is 2.65%, Quarterly performance is -1.58%, 6 Months performance is -0.03% and yearly performance percentage is 14.03%. Year to Date performance value (YTD perf) value is 1.74%. The Stock currently has a Weekly Volatility of 1.82% and Monthly Volatility of 1.80%.